XML 49 R32.htm IDEA: XBRL DOCUMENT
v3.25.2

Supplemental Equity and Accumulated Other Comprehensive Income (Loss) Information (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2025
Notes Tables |
Schedule of changes in Accumulated Other Comprehensive Income (Loss) | Changes in Accumulated other comprehensive income (loss) attributable to Bio-Techne by component (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Unrealized | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Gains | ​ | Foreign | ​ | ​ | ​
​ | ​ | (Losses) on | ​ | Currency | ​ | ​ | ​
​ | ​ | Derivative | ​ | Translation | ​ | ​ | ​
​ | ​ | Instruments |  | Adjustments |  | Total
Balance as of June 30, 2022, net of tax | ​ | $ | 8,069 | ​ | $ | (83,269) | ​ | $ | (75,200)
Other comprehensive income (loss), before tax, attributable to Bio-Techne: : | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Amounts before reclassifications (1) | ​ | ​ | 1,340 | ​ | ​ | 4,191 | ​ | ​ | 5,531
Amounts reclassified out | ​ | ​ | 4,526 | ​ | ​ | 152 | ​ | ​ | 4,678
Total other comprehensive income (loss), before tax, attributable to Bio-Techne: | ​ | ​ | 5,866 | ​ | ​ | 4,343 | ​ | ​ | 10,209
Tax expense | ​ | ​ | (1,073) | ​ | ​ | — | ​ | ​ | (1,073)
Total other comprehensive income (loss), net of tax, attributable to Bio-Techne: | ​ | ​ | 4,793 | ​ | ​ | 4,343 | ​ | ​ | 9,136
Balance as of June 30, 2023, net of tax(2) | ​ | $ | 12,862 | ​ | $ | (78,926) | ​ | $ | (66,064)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Other comprehensive income (loss), before tax: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Amounts before reclassifications | ​ | ​ | (12,632) | ​ | ​ | (9,941) | ​ | ​ | (22,573)
Amounts reclassified out | ​ | ​ | 10,317 | ​ | ​ | 3,210 | ​ | ​ | 13,527
Total other comprehensive income (loss), before tax | ​ | ​ | (2,315) | ​ | ​ | (6,731) | ​ | ​ | (9,046)
Tax expense | ​ | ​ | (2,445) | ​ | ​ | (761) | ​ | ​ | (3,206)
Total other comprehensive income (loss), net of tax | ​ |  | (4,760) | ​ | ​ | (7,492) | ​ | ​ | (12,252)
Balance as of June 30, 2024, net of tax(2) | ​ | $ | 8,102 | ​ | $ | (86,418) | ​ | $ | (78,316)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Other comprehensive income (loss), before tax: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Amounts before reclassifications | ​ | ​ | (12,011) | ​ | ​ | 21,895 | ​ | ​ | 9,884
Amounts reclassified out | ​ | ​ | 8,448 | ​ | ​ | 2,761 | ​ | ​ | 11,209
Total other comprehensive income (loss), before tax | ​ | ​ | (3,563) | ​ | ​ | 24,656 | ​ | ​ | 21,093
Tax expense | ​ | ​ | (2,003) | ​ | ​ | (654) | ​ | ​ | (2,657)
Total other comprehensive income (loss), net of tax | ​ |  | (5,566) | ​ | ​ | 24,002 | ​ | ​ | 18,436
Balance as of June 30, 2025, net of tax(2) | ​ | $ | 2,536 | ​ | $ | (62,416) | ​ | $ | (59,880)
(1) | Amounts before reclassifications related to foreign currency translation adjustments in the table above includes the amount attributable to Bio-Techne and excludes the $33 thousand attributable to the non-controlling interest in Eminence as of June 30, 2023.
(2) | The Company had a net deferred tax liability for its cash flow hedge of $0.8 million, $2.5 million, and $4.0 million as of June 30, 2025, 2024 and 2023.

X
- Definition Tabular disclosure of the components of accumulated other comprehensive income (loss). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 + Details
Name: | us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration